Related references
Note: Only part of the references are listed.A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: Application to plasma and brain pharmacokinetics
Lauriane Goldwirt et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Determination of temozolomide in serum and brain tumor with micellar electrokinetic capillary chromatography
Melinda Andrasi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Evaluation of the exposure equivalence of oral versus intravenous temozolomide
Blanca D. Diez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Disposition and pharmacokinetics of temozolomide in rat
L Reyderman et al.
XENOBIOTICA (2004)
Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates
M Patel et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma
H Kim et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2001)
Share Paper
